2019 Q4 Form 10-K Financial Statement
#000156459020010123 Filed on March 11, 2020
Income Statement
| Concept | 2019 Q4 | 2019 | 2018 Q4 |
|---|---|---|---|
| Revenue | $1.390M | $7.199M | $1.988M |
| YoY Change | -30.08% | 15.06% | |
| Cost Of Revenue | $1.750M | $8.850M | $1.200M |
| YoY Change | 45.83% | 110.41% | |
| Gross Profit | -$360.0K | -$1.651M | $788.0K |
| YoY Change | -145.69% | -180.5% | |
| Gross Profit Margin | -25.9% | -22.93% | 39.64% |
| Selling, General & Admin | $8.642M | $51.55M | $14.81M |
| YoY Change | -41.66% | 69.37% | |
| % of Gross Profit | 1879.95% | ||
| Research & Development | $838.0K | $4.530M | $1.244M |
| YoY Change | -32.64% | 63.18% | |
| % of Gross Profit | 157.87% | ||
| Depreciation & Amortization | $374.0K | $1.420M | $236.0K |
| YoY Change | 58.47% | 127.56% | 237.14% |
| % of Gross Profit | 29.95% | ||
| Operating Expenses | $9.480M | $56.08M | $16.06M |
| YoY Change | -40.96% | 68.86% | |
| Operating Profit | -$9.840M | -$57.73M | -$15.27M |
| YoY Change | -35.56% | 85.27% | |
| Interest Expense | $104.0K | $250.0K | $340.0K |
| YoY Change | -69.41% | 1685.71% | |
| % of Operating Profit | |||
| Other Income/Expense, Net | $788.0K | ||
| YoY Change | 133.14% | ||
| Pretax Income | -$9.736M | -$56.94M | -$14.93M |
| YoY Change | -34.79% | 84.74% | |
| Income Tax | $7.000K | $15.00K | $7.000K |
| % Of Pretax Income | |||
| Net Earnings | -$9.743M | -$56.96M | -$14.94M |
| YoY Change | -34.77% | 84.73% | |
| Net Earnings / Revenue | -700.94% | -791.18% | -751.36% |
| Basic Earnings Per Share | |||
| Diluted Earnings Per Share | -$18.02M | -$108.3M | -$1.178M |
| COMMON SHARES | |||
| Basic Shares Outstanding | 13.41M | ||
| Diluted Shares Outstanding |
Balance Sheet
| Concept | 2019 Q4 | 2019 | 2018 Q4 |
|---|---|---|---|
| SHORT-TERM ASSETS | |||
| Cash & Short-Term Investments | $30.58M | $30.58M | $64.32M |
| YoY Change | -52.46% | -52.45% | |
| Cash & Equivalents | $14.58M | $14.58M | $64.32M |
| Short-Term Investments | $15.99M | $15.99M | $0.00 |
| Other Short-Term Assets | $1.860M | $3.908M | $1.501M |
| YoY Change | 23.92% | 160.53% | |
| Inventory | $2.777M | $1.292M | $2.097M |
| Prepaid Expenses | |||
| Receivables | $786.0K | $223.0K | $1.320M |
| Other Receivables | $0.00 | $0.00 | $0.00 |
| Total Short-Term Assets | $36.00M | $36.00M | $69.23M |
| YoY Change | -48.0% | -48.0% | 589.43% |
| LONG-TERM ASSETS | |||
| Property, Plant & Equipment | $5.050M | $6.979M | $4.757M |
| YoY Change | 6.16% | 46.62% | 310.44% |
| Goodwill | |||
| YoY Change | |||
| Intangibles | |||
| YoY Change | |||
| Long-Term Investments | |||
| YoY Change | |||
| Other Assets | $196.0K | $1.102M | $45.00K |
| YoY Change | 335.56% | 2655.0% | -33.82% |
| Total Long-Term Assets | $8.081M | $8.081M | $4.802M |
| YoY Change | 68.28% | 68.35% | 291.36% |
| TOTAL ASSETS | |||
| Total Short-Term Assets | $36.00M | $36.00M | $69.23M |
| Total Long-Term Assets | $8.081M | $8.081M | $4.802M |
| Total Assets | $44.08M | $44.08M | $74.04M |
| YoY Change | -40.46% | -40.46% | 556.98% |
| SHORT-TERM LIABILITIES | |||
| YoY Change | |||
| Accounts Payable | $1.532M | $1.220M | $1.125M |
| YoY Change | 36.18% | 8.93% | 164.08% |
| Accrued Expenses | $2.642M | $2.678M | $2.809M |
| YoY Change | -5.95% | -4.7% | 766.98% |
| Deferred Revenue | $2.029M | $1.723M | |
| YoY Change | 17.76% | 0.53% | |
| Short-Term Debt | $0.00 | $0.00 | $0.00 |
| YoY Change | |||
| Long-Term Debt Due | $293.0K | $293.0K | $293.0K |
| YoY Change | 0.0% | 1.03% | |
| Total Short-Term Liabilities | $6.814M | $6.814M | $5.950M |
| YoY Change | 14.52% | 14.52% | 125.98% |
| LONG-TERM LIABILITIES | |||
| Long-Term Debt | $265.0K | $265.0K | $557.0K |
| YoY Change | -52.42% | -52.68% | |
| Other Long-Term Liabilities | $3.852M | $3.852M | $56.00K |
| YoY Change | 6778.57% | 369.76% | -30.86% |
| Total Long-Term Liabilities | $4.117M | $4.117M | $56.00K |
| YoY Change | 7251.79% | 198.33% | -30.86% |
| TOTAL LIABILITIES | |||
| Total Short-Term Liabilities | $6.814M | $6.814M | $5.950M |
| Total Long-Term Liabilities | $4.117M | $4.117M | $56.00K |
| Total Liabilities | $10.93M | $10.93M | $7.330M |
| YoY Change | 49.13% | 49.13% | -61.18% |
| SHAREHOLDERS EQUITY | |||
| Retained Earnings | -$117.2M | -$60.22M | |
| YoY Change | 94.55% | 104.91% | |
| Common Stock | $150.3M | $126.9M | |
| YoY Change | 18.4% | 482.92% | |
| Preferred Stock | |||
| YoY Change | |||
| Treasury Stock (at cost) | |||
| YoY Change | |||
| Treasury Stock Shares | |||
| Shareholders Equity | $33.15M | $33.15M | $66.73M |
| YoY Change | |||
| Total Liabilities & Shareholders Equity | $44.08M | $44.08M | $74.04M |
| YoY Change | -40.46% | -40.46% | 556.98% |
Cashflow Statement
| Concept | 2019 Q4 | 2019 | 2018 Q4 |
|---|---|---|---|
| OPERATING ACTIVITIES | |||
| Net Income | -$9.743M | -$56.96M | -$14.94M |
| YoY Change | -34.77% | 84.73% | |
| Depreciation, Depletion And Amortization | $374.0K | $1.420M | $236.0K |
| YoY Change | 58.47% | 127.56% | 237.14% |
| Cash From Operating Activities | -$9.572M | -$33.17M | -$8.399M |
| YoY Change | 13.97% | 79.24% | 459.93% |
| INVESTING ACTIVITIES | |||
| Capital Expenditures | -$48.00K | $268.0K | -$158.0K |
| YoY Change | -69.62% | -53.95% | -41.48% |
| Acquisitions | |||
| YoY Change | |||
| Other Investing Activities | $10.00M | -$15.76M | $0.00 |
| YoY Change | |||
| Cash From Investing Activities | $9.952M | -$16.03M | -$158.0K |
| YoY Change | -6398.73% | 2654.64% | -41.48% |
| FINANCING ACTIVITIES | |||
| Cash Dividend Paid | |||
| YoY Change | |||
| Common Stock Issuance & Retirement, Net | $37.00K | ||
| YoY Change | -99.95% | ||
| Debt Paid & Issued, Net | |||
| YoY Change | |||
| Cash From Financing Activities | -308.0K | -526.0K | 67.96M |
| YoY Change | -100.45% | -100.7% | 650.91% |
| NET CHANGE | |||
| Cash From Operating Activities | -9.572M | -33.17M | -8.399M |
| Cash From Investing Activities | 9.952M | -16.03M | -158.0K |
| Cash From Financing Activities | -308.0K | -526.0K | 67.96M |
| Net Change In Cash | 72.00K | -49.73M | 59.40M |
| YoY Change | -99.88% | -188.68% | 715.93% |
| FREE CASH FLOW | |||
| Cash From Operating Activities | -$9.572M | -$33.17M | -$8.399M |
| Capital Expenditures | -$48.00K | $268.0K | -$158.0K |
| Free Cash Flow | -$9.524M | -$33.44M | -$8.241M |
| YoY Change | 15.57% | 75.18% | 570.0% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2019Q4 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
2029000 | |
| CY2019Q4 | rmed |
Equipment Financing Obligations Current
EquipmentFinancingObligationsCurrent
|
293000 | |
| CY2019Q4 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
318000 | |
| CY2018 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
4206000 | |
| CY2018 | us-gaap |
Gross Profit
GrossProfit
|
2051000 | |
| CY2018 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
30435000 | |
| CY2018 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
2776000 | |
| CY2018 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
352000 | |
| CY2018Q4 | rmed |
Equipment Financing Obligations Noncurrent
EquipmentFinancingObligationsNoncurrent
|
557000 | |
| CY2018Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
5950000 | |
| CY2018Q4 | us-gaap |
Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
|
767000 | |
| CY2019Q4 | us-gaap |
Liabilities
Liabilities
|
10931000 | |
| CY2019Q4 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
2620000 | |
| CY2019Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
| CY2019Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
1000 | |
| CY2019Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
150280000 | |
| CY2019Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-117157000 | |
| CY2019Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
||
| CY2019Q4 | us-gaap |
Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
|
1232000 | |
| CY2019Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
26000 | |
| CY2018Q4 | us-gaap |
Liabilities
Liabilities
|
7330000 | |
| CY2018Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
||
| CY2019Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
33150000 | |
| CY2018Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
1000 | |
| CY2018Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
126925000 | |
| CY2018Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-60221000 | |
| CY2018Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
66705000 | |
| CY2019Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
44081000 | |
| CY2019Q4 | rmed |
Equipment Financing Obligations Noncurrent
EquipmentFinancingObligationsNoncurrent
|
265000 | |
| CY2018Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
| CY2018Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
74035000 | |
| CY2018 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
6257000 | |
| CY2019 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
7199000 | |
| CY2019Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
6814000 | |
| CY2019Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
10000000 | |
| CY2019Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | |
| CY2018 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-30832000 | |
| CY2018 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-3.34 | |
| CY2019 | us-gaap |
Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
|
20697000 | |
| CY2019 | us-gaap |
Gross Profit
GrossProfit
|
-1651000 | |
| CY2019 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
51549000 | |
| CY2019 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
1038000 | |
| CY2019 | us-gaap |
Interest Expense
InterestExpense
|
250000 | |
| CY2019 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
788000 | |
| CY2018Q4 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
56000 | |
| CY2019Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
| CY2018Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
| CY2018Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
10000000 | |
| CY2018Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | |
| CY2019Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
| CY2018Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
| CY2019Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
300000000 | |
| CY2018Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
300000000 | |
| CY2019Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
13770349 | |
| CY2018Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
12689251 | |
| CY2019Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
13770349 | |
| CY2018Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
12689251 | |
| CY2019 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
8850000 | |
| CY2018 | us-gaap |
Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
|
1000 | |
| CY2018 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
14728000 | |
| CY2019 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
15000 | |
| CY2018 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
9230000 | |
| CY2019 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
26000 | |
| CY2018 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
78806000 | |
| CY2018 | us-gaap |
Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
|
3556000 | |
| CY2019 | us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
26000 | |
| CY2018 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-30832000 | |
| CY2017Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-7615000 | |
| CY2018 | rmed |
Settlement Of Stock Based Compensation Liability
SettlementOfStockBasedCompensationLiability
|
18243000 | |
| CY2018 | rmed |
Adjustments To Additional Paid In Capital Share Based Compensation Forfeitures Of Liability Classified Awards
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationForfeituresOfLiabilityClassifiedAwards
|
1313000 | |
| CY2018 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
10346000 | |
| CY2018Q4 | us-gaap |
Cumulative Effect Of New Accounting Principle In Period Of Adoption
CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption
|
21000 | |
| CY2018Q4 | rmed |
Stockholders Equity Adjusted Balance
StockholdersEquityAdjustedBalance
|
66726000 | |
| CY2019 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
-188000 | |
| CY2019 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
23543000 | |
| CY2018 | rmed |
Payment For Underwriters Discount
PaymentForUnderwritersDiscount
|
5338000 | |
| CY2019 | us-gaap |
Profit Loss
ProfitLoss
|
-56957000 | |
| CY2018 | us-gaap |
Profit Loss
ProfitLoss
|
-30832000 | |
| CY2019 | us-gaap |
Depreciation
Depreciation
|
1420000 | |
| CY2018 | us-gaap |
Depreciation
Depreciation
|
624000 | |
| CY2019 | rmed |
Operating Lease Right Of Use Asset Amortization
OperatingLeaseRightOfUseAssetAmortization
|
330000 | |
| CY2019 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
283000 | |
| CY2018 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
255000 | |
| CY2019 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
23543000 | |
| CY2019 | us-gaap |
Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
|
-123000 | |
| CY2019 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-251000 | |
| CY2018 | us-gaap |
Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
|
-150000 | |
| CY2018 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-18508000 | |
| CY2019 | us-gaap |
Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
|
36461000 | |
| CY2018 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
582000 | |
| CY2019 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-16032000 | |
| CY2019 | rmed |
Payments For Restricted Stock Tax Liability On Settlement
PaymentsForRestrictedStockTaxLiabilityOnSettlement
|
225000 | |
| CY2019 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
37000 | |
| CY2018 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
78806000 | |
| CY2018 | us-gaap |
Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
|
3556000 | |
| CY2019 | rmed |
Payments On Equipment Financing
PaymentsOnEquipmentFinancing
|
338000 | |
| CY2018 | rmed |
Payments On Equipment Financing
PaymentsOnEquipmentFinancing
|
82000 | |
| CY2019 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-526000 | |
| CY2018 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
75168000 | |
| CY2019 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-49731000 | |
| CY2018 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
56078000 | |
| CY2018Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
64315000 | |
| CY2017Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
8237000 | |
| CY2019Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
14584000 | |
| CY2018 | us-gaap |
Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
|
831000 | |
| CY2019 | rmed |
Transfer From Inventories To Property And Equipment For Lasers
TransferFromInventoriesToPropertyAndEquipmentForLasers
|
1505000 | |
| CY2018 | rmed |
Transfer From Inventories To Property And Equipment For Lasers
TransferFromInventoriesToPropertyAndEquipmentForLasers
|
2848000 | |
| CY2018 | us-gaap |
Interest Paid Net
InterestPaidNet
|
11000 | |
| CY2019 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
30000 | |
| CY2019 | rmed |
Operating Loss Carryforwards Expiration Year
OperatingLossCarryforwardsExpirationYear
|
2029 | |
| CY2019Q4 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
0 | |
| CY2019Q4 | us-gaap |
Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Amount Of Unrecorded Benefit
SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit
|
0 | |
| CY2019Q4 | us-gaap |
Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
|
0 | |
| CY2019 | rmed |
Income Tax Examination Years Under Examination
IncomeTaxExaminationYearsUnderExamination
|
2015 and later | |
| CY2019 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Use of estimates<font style="font-weight:normal;font-style:normal;">—The </font><font style="color:#000000;font-weight:normal;font-style:normal;">financial statements of the Company have been prepared by management in accordance with accounting principles generally accepted in the United States of America. The</font><font style="font-weight:normal;font-style:normal;"> preparation of the financial statements requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities and reported disclosures of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from those estimates. The Company’s financial statements are based upon a number of estimates, including but not limited to, allowance for doubtful accounts, reserves for warranty costs including product recalls, evaluation of probable loss contingencies, fair value of stock option awards granted and revenue recognition for multiple performance obligations. </font></p> | |
| CY2019 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<p style="margin-top:9pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Concentrations of credit risk<font style="font-weight:normal;font-style:normal;">—Credit risk represents the accounting loss that would be recognized at the reporting date if counterparties failed completely to perform as contracted. Concentrations of credit risk that arise from financial instruments exist for groups of customers or counterparties when they have similar economic characteristics that would cause their ability to meet contractual obligations to be similarly affected by changes in economic or other conditions described below. </font></p> <p style="margin-top:9pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial instruments, which potentially subject the Company to concentration of credit risk, consist of cash, cash equivalents and short-term investments balances maintained in excess of Federal Depository Insurance Corporation limits, and accounts receivable which have no collateral or security. The Company monitors the financial condition of the banks in which it currently has deposits. The Company has not experienced any significant losses in this respect and believes that it is not exposed to any significant related risk. </p> <p style="margin-top:9pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exposure to losses on accounts receivable is dependent on the individual customer’s financial condition. The Company monitors its exposure to credit losses and reserves for those accounts receivable that it deems to be not collectible. </p> <p style="margin-top:9pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">One of the Company’s customers represented 10% of accounts receivable as of December 31, 2019 and 2018. <font style="font-size:12pt;">  </font></p> <p style="margin-top:9pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">No individual customer represented greater than 10% of total net revenue for the years ended December 31, 2019 or 2018. </p> | |
| CY2019Q4 | us-gaap |
Capitalized Contract Cost Net
CapitalizedContractCostNet
|
400000 | |
| CY2019Q1 | us-gaap |
Capitalized Contract Cost Net
CapitalizedContractCostNet
|
400000 | |
| CY2019 | us-gaap |
Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
|
700000 | |
| CY2018 | us-gaap |
Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
|
500000 | |
| CY2018Q4 | us-gaap |
Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
|
1333000 | |
| CY2019Q1 | us-gaap |
New Accounting Pronouncement Or Change In Accounting Principle Cumulative Effect Of Change On Equity Or Net Assets1
NewAccountingPronouncementOrChangeInAccountingPrincipleCumulativeEffectOfChangeOnEquityOrNetAssets1
|
21000 | |
| CY2019Q4 | us-gaap |
Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
|
15967000 | |
| CY2019Q4 | us-gaap |
Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
|
26000 | |
| CY2019Q4 | us-gaap |
Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
|
15993000 | |
| CY2019Q4 | us-gaap |
Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
|
2300000 | |
| CY2018Q3 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
| CY2018Q3 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
25000000 | |
| CY2018Q3 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
10000000 | |
| CY2019Q4 | us-gaap |
Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
|
30600000 | |
| CY2018Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
214000 | |
| CY2017Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
12000 | |
| CY2019 | us-gaap |
Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
|
142000 | |
| CY2018 | us-gaap |
Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
|
53000 | |
| CY2019Q1 | us-gaap |
Contract With Customer Liability
ContractWithCustomerLiability
|
2800000 | |
| CY2019 | us-gaap |
Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
|
1900000 | |
| CY2019 | rmed |
Revenue Remaining Service Period To Recognize Deferred Revenue
RevenueRemainingServicePeriodToRecognizeDeferredRevenue
|
2024 | |
| CY2019Q4 | us-gaap |
Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
|
215000 | |
| CY2018Q4 | us-gaap |
Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
|
88000 | |
| CY2019Q4 | us-gaap |
Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
|
262000 | |
| CY2018Q4 | us-gaap |
Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
|
676000 | |
| CY2019Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
7159000 | |
| CY2018Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
6070000 | |
| CY2019Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
2109000 | |
| CY2018Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
1313000 | |
| CY2019Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
1163000 | |
| CY2018Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
1734000 | |
| CY2019Q4 | us-gaap |
Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
|
338000 | |
| CY2018Q4 | us-gaap |
Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
|
112000 | |
| CY2019Q4 | rmed |
Accrued Services Current
AccruedServicesCurrent
|
1141000 | |
| CY2018Q4 | rmed |
Accrued Services Current
AccruedServicesCurrent
|
963000 | |
| CY2017Q4 | us-gaap |
Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
|
87000 | |
| CY2019 | us-gaap |
Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
|
889000 | |
| CY2018 | us-gaap |
Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
|
287000 | |
| CY2019 | us-gaap |
Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
|
-28000 | |
| CY2019 | us-gaap |
Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
|
635000 | |
| CY2018 | us-gaap |
Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
|
262000 | |
| CY2019 | us-gaap |
Product Warranty Expense
ProductWarrantyExpense
|
900000 | |
| CY2018 | us-gaap |
Product Warranty Expense
ProductWarrantyExpense
|
300000 | |
| CY2019 | rmed |
Operating Lease Number Of Leases
OperatingLeaseNumberOfLeases
|
2 | |
| CY2019Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
23148000 | |
| CY2018Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
14759000 | |
| CY2019Q4 | us-gaap |
Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
|
1026000 | |
| CY2018Q4 | us-gaap |
Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
|
888000 | |
| CY2019Q4 | us-gaap |
Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
|
0.07 | |
| CY2019Q4 | us-gaap |
Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
|
P8Y | |
| CY2019 | us-gaap |
Operating Lease Expense
OperatingLeaseExpense
|
500000 | |
| CY2019 | us-gaap |
Operating Lease Payments
OperatingLeasePayments
|
500000 | |
| CY2018 | us-gaap |
Lease And Rental Expense
LeaseAndRentalExpense
|
400000 | |
| CY2019Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
|
514000 | |
| CY2019Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
|
528000 | |
| CY2019Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
|
432000 | |
| CY2019Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
|
445000 | |
| CY2019Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
|
459000 | |
| CY2019Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
|
1459000 | |
| CY2019Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
|
3837000 | |
| CY2019Q4 | us-gaap |
Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
|
899000 | |
| CY2019Q4 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
2938000 | |
| CY2018Q4 | us-gaap |
Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
|
500000 | |
| CY2018Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
|
514000 | |
| CY2018Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
|
528000 | |
| CY2018Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
|
432000 | |
| CY2018Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
|
445000 | |
| CY2018Q4 | us-gaap |
Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
|
1918000 | |
| CY2018Q4 | us-gaap |
Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
|
4337000 | |
| CY2019Q4 | us-gaap |
Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
|
293000 | |
| CY2019Q4 | us-gaap |
Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
|
265000 | |
| CY2019Q4 | us-gaap |
Long Term Debt
LongTermDebt
|
558000 | |
| CY2019Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | |
| CY2018Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | |
| CY2019 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
21929000 | |
| CY2018 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
13887000 | |
| CY2019 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P1Y7M6D | |
| CY2019 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.210 | |
| CY2018 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.210 | |
| CY2019 | us-gaap |
Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
|
0.019 | |
| CY2018 | us-gaap |
Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
|
0.027 | |
| CY2019 | us-gaap |
Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
|
0.004 | |
| CY2018 | us-gaap |
Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
|
0.020 | |
| CY2019 | us-gaap |
Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
|
0.095 | |
| CY2018 | us-gaap |
Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
|
0.022 | |
| CY2019 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
-0.130 | |
| CY2018 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
-0.195 | |
| CY2019 | us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
15000 | |
| CY2018 | us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
10000 | |
| CY2019 | us-gaap |
Current Federal State And Local Tax Expense Benefit
CurrentFederalStateAndLocalTaxExpenseBenefit
|
15000 | |
| CY2018 | us-gaap |
Current Federal State And Local Tax Expense Benefit
CurrentFederalStateAndLocalTaxExpenseBenefit
|
10000 | |
| CY2019Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
16096000 | |
| CY2018Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
6990000 | |
| CY2019Q4 | rmed |
Deferred Tax Assets Operating Lease Liabilities
DeferredTaxAssetsOperatingLeaseLiabilities
|
766000 | |
| CY2019Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther
|
61000 | |
| CY2018Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther
|
88000 | |
| CY2019Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves
|
301000 | |
| CY2018Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves
|
203000 | |
| CY2019Q4 | us-gaap |
Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
|
850000 | |
| CY2018Q4 | us-gaap |
Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
|
661000 | |
| CY2019Q4 | us-gaap |
Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
|
253000 | |
| CY2018Q4 | us-gaap |
Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
|
353000 | |
| CY2019Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
|
4821000 | |
| CY2018Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
|
6464000 | |
| CY2018Q4 | us-gaap |
Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
|
888000 | |
| CY2019Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
21291000 | |
| CY2018Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
13871000 | |
| CY2019Q4 | rmed |
Deferred Tax Liabilities Operating Lease Right Of Use Assets
DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets
|
739000 | |
| CY2019Q4 | us-gaap |
Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
|
92000 | |
| CY2019Q4 | us-gaap |
Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
|
1857000 | |
| CY2019 | rmed |
Audit Committee Findings Description
AuditCommitteeFindingsDescription
|
The primary investigative findings were: (i) the DABRA catheter frequently failed to calibrate and occasionally overheated, posing a risk of injury to physicians and patients; (ii) the Company’s explanations regarding its fourth quarter 2018 and first quarter 2019 sales created a risk of confusion because they did not explicitly reference inconsistent DABRA catheter performance and catheter failures; (iii) the Company failed to timely make at least two Medical Device Reports, or MDRs, to the FDA; (iv) the Company, out of a concern for the DABRA catheters’ performance, engaged in systematic efforts to replace product held by customers, which constituted product recalls, but were not documented as such, (v) the Company lack documentation of sufficient detail and specificity to support certain payments to physicians, ostensibly for training and consulting services, and as to three physicians did not accurately reflect the purpose and nature of approximately $300,000 of payments, which could be perceived as an improper attempt to obtain business or to gain special advantage, (vi) while the indication for use in the 510(k) clearance the Company obtained for the DABRA system is not for atherectomy, the Company’s salespeople were instructed to characterize DABRA as performing atherectomy and to encourage doctors to seek reimbursement using atherectomy codes, (vii) the Company’s determinations to direct potentially valuable benefits and opportunities to doctors were informed in part by sales prospects, and (viii) the Company received complaints regarding regulatory or compliance concerns that, because they implicated executive officers, should have been brought to the attention of the Board or the Audit Committee, but were not. | |
| CY2019 | rmed |
Payments That Lack Documentation Of Sufficent Detail
PaymentsThatLackDocumentationOfSufficentDetail
|
300000 | |
| CY2019 | us-gaap |
General Discussion Of Pension And Other Postretirement Benefits
GeneralDiscussionOfPensionAndOtherPostretirementBenefits
|
In January 2019, the Company established a defined contribution plan under Section 401(k) of the Internal Revenue Code (“401(k) Plan”) that the Company administers for participating employees’ contributions. | |
| CY2019 | us-gaap |
Description Of Defined Contribution Pension And Other Postretirement Plans
DescriptionOfDefinedContributionPensionAndOtherPostretirementPlans
|
All full-time employees are eligible under the 401(k) Plan. The Company will make contributions, based on a match of 100% of each employee’s contribution up to 3% and 50% of contributions between 3% and 5%, with the match-eligible contribution being limited to 4% of the employee’s eligible compensation. | |
| CY2019 | us-gaap |
Defined Contribution Plan Administrative Expenses
DefinedContributionPlanAdministrativeExpenses
|
300000 | |
| CY2019 | us-gaap |
Number Of Operating Segments
NumberOfOperatingSegments
|
2 | |
| CY2019 | us-gaap |
Revenues
Revenues
|
7199000 | |
| CY2018 | us-gaap |
Revenues
Revenues
|
6257000 |
